Polymorphism in miRNA-1 target site and circulating miRNA-1 phenotype are associated with the decreased risk and prognosis of coronary artery disease

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 8, 2014, Pages 5093-5102

  Wang, Lina ^a   Zhi, Hong ^a   Li, Yongjun ^a   Ma, Genshan ^a   Ye, Xingzhou ^a   Yu, Xiaojin ^a   Yang, Tian ^a   Jin, Han ^a   Lu, Zuhong ^a   Wei, Pingmin ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Coronary artery disease; MACE; MiRNAs; Polymorphism; Target gene

Indexed keywords

COG6 PROTEIN, HUMAN; MICRORNA; MIRN1 MICRORNA, HUMAN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

AGED; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; AGED; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 84907829433     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D and Turner MB. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation 2014; 129: e28-e292.
2. Wang F, Xu CQ, He Q, Cai JP, Li XC, Wang D, Xiong X, Liao YH, Zeng QT, Yang YZ, Cheng X, Li C, Yang R, Wang CC, Wu G, Lu QL, Bai Y, Huang YF, Yin D, Yang Q, Wang XJ, Dai DP, Zhang RF, Wan J, Ren JH, Li SS, Zhao YY, Fu FF, Huang Y, Li QX, Shi SW, Lin N, Pan ZW, Li Y, Yu B, Wu YX, Ke YH, Lei J, Wang N, Luo CY, Ji LY, Gao LJ, Li L, Liu H, Huang EW, Cui J, Jia N, Ren X, Li H, Ke T, Zhang XQ, Liu JY, Liu MG, Xia H, Yang B, Shi LS, Xia YL, Tu X and Wang QK. Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet 2011; 43: 345-349.
3. Bampali K, Mouzarou A, Lamnisou K and Babalis D. Genetics and coronary artery disease: present and future. Hellenic J Cardiol 2014; 55: 156-163.
4. Broeckel U, Hengstenberg C, Mayer B, Holmer S, Martin LJ, Comuzzie AG, Blangero J, Nurnberg P, Reis A, Riegger GA, Jacob HJ and Schunkert H. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 2002; 30: 210-214.
5. Link N and Tanner M. Coronary artery disease: Part 1. Epidemiology and diagnosis. West J Med 2001; 174: 257-261.
6. Winter J and Diederichs S. MicroRNA biogenesis and cancer. Methods Mol Biol 2011; 676: 3-22.
7. Sethupathy P and Collins FS. MicroRNA target site polymorphisms and human disease. Trends Genet 2008; 24: 489-497.
8. Bhattacharya A, Ziebarth JD and Cui Y. PolymiRTS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways. Nucleic Acids Res 2014; 42: D86-91.
9. Yang F, Chen F, Gu J, Zhang W, Luo J and Guan X. Genetic variant rs1058240 at the microRNA-binding site in the GATA3 gene may regulate its mRNA expression. Biomed Rep 2014; 2: 404-407.
10. Naccarati A, Pardini B, Stefano L, Landi D, Slyskova J, Novotny J, Levy M, Polakova V, Lipska L and Vodicka P. Polymorphisms in miRNA-binding sites of nucleotide excision repair genes and colorectal cancer risk. Carcinogenesis 2012; 33: 1346-1351.
11. Nossent AY, Hansen JL, Doggen C, Quax PH, Sheikh SP and Rosendaal FR. SNPs in microRNA binding sites in 3'-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction. Am J Hypertens 2011; 24: 999-1006.
12. Mallick B and Ghosh Z. A complex crosstalk between polymorphic microRNA target sites and AD prognosis. RNA Biol 2011; 8: 665-673.
13. Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatzigeorgiou AG and Antonarakis SE. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 2007; 81: 405-413.
14. Heidersbach A, Saxby C, Carver-Moore K, Huang Y, Ang YS, de Jong PJ, Ivey KN and Srivastava D. microRNA-1 regulates sarcomere formation and suppresses smooth muscle gene expression in the mammalian heart. Elife 2013; 2: e01323.
15. Wei Y, Peng S, Wu M, Sachidanandam R, Tu Z, Zhang S, Falce C, Sobie EA, Lebeche D and Zhao Y. Multifaceted roles of miR-1s in repressing the fetal gene program in the heart. Cell Res 2014; 24: 278-292.
16. He B, Xiao J, Ren AJ, Zhang YF, Zhang H, Chen M, Xie B, Gao XG and Wang YW. Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J Biomed Sci 2011; 18: 22.
17. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW and Lo YM. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 2008; 54: 482-490.
18. Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K, Kempf T, Wollert KC and Thum T. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 2011; 51: 872-875.
19. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, Rubino M, Carena MC, Spazzafumo L, De Simone M, Micheli B, Biglioli P, Achilli F, Martelli F, Maggiolini S, Marenzi G, Pompilio G and Capogrossi MC. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010; 31: 2765-2773.
20. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Roxe T, Muller-Ardogan M, Bonauer A, Zeiher AM and Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010; 107: 677-684.
21. Li S, Zhu J, Zhang W, Chen Y, Zhang K, Popescu LM, Ma X, Lau WB, Rong R, Yu X, Wang B, Li Y, Xiao C, Zhang M, Wang S, Yu L, Chen AF, Yang X and Cai J. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 2011; 124: 175-184.
22. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE and Pinto YM. MiR423-5p as a circulating biomarker for heart failure. Circ Res 2010; 106: 1035-1039.
23. Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, Li K, Yu B, Li Z, Wang R, Wang L, Li Q, Wang N, Shan H, Li Z and Yang B. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 2010; 391: 73-77.
24. Ziebarth JD, Bhattacharya A, Chen A and Cui Y. PolymiRTS Database 2.0: linking polymorphisms in microRNA target sites with human diseases and complex traits. Nucleic Acids Res 2012; 40: D216-221.
25. Luo X, Lin H, Pan Z, Xiao J, Zhang Y, Lu Y, Yang B and Wang Z. Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J Biol Chem 2008; 283: 20045-20052.
26. Small EM, Sutherland LB, Rajagopalan KN, Wang S and Olson EN. MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling. Circ Res 2010; 107: 1336-1344.
27. Alshalalfa M, Bader GD, Bismar TA and Alhajj R. Coordinate microRNA-mediated regulation of protein complexes in prostate cancer. PLoS One 2013; 8: e84261.
28. Feng B, Cao Y, Chen S, Ruiz M and Chakrabarti S. miRNA-1 regulates endothelin-1 in diabetes. Life Sci 2014; 98: 18-23.
29. Catalucci D, Gallo P and Condorelli G. MicroRNAs in cardiovascular biology and heart disease. Circ Cardiovasc Genet 2009; 2: 402-408.
30. Si H, Sun X, Chen Y, Cao Y, Chen S, Wang H and Hu C. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J Cancer Res Clin Oncol 2013; 139: 223-229.
31. Wang Q, Huang Z, Ni S, Xiao X, Xu Q, Wang L, Huang D, Tan C, Sheng W and Du X. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. PLoS One 2012; 7: e44398.
32. Gan CS, Wang CW and Tan KS. Circulatory microRNA-145 expression is increased in cerebral ischemia. Genet Mol Res 2012; 11: 147-152.
33. Long G, Wang F, Duan Q, Chen F, Yang S, Gong W, Wang Y, Chen C and Wang DW. Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci 2012; 8: 811-818.
34. Ali R, Huang Y, Maher SE, Kim RW, Giordano FJ, Tellides G and Geirsson A. miR-1 mediated suppression of Sorcin regulates myocardial contractility through modulation of Ca2+ signaling. J Mol Cell Cardiol 2012; 52: 1027-1037.
35. Nohata N, Hanazawa T, Kikkawa N, Sakurai D, Sasaki K, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nakagawa M, Okamoto Y and Seki N. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma. Int J Oncol 2011; 39: 1099-1107.
36. Lin Y, Nie Y, Zhao J, Chen X, Ye M, Li Y, Du Y, Cao J, Shen B and Li Y. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility. Carcinogenesis 2012; 33: 2377-2383.
37. Ramamoorthy RD, Nallasamy V, Reddy R, Esther N and Maruthappan Y. A review of C-reactive protein: A diagnostic indicator in periodontal medicine. J Pharm Bioallied Sci 2012; 4: S422-426.
38. Huang Y, Jing J, Zhao XQ, Wang CX, Wang YL, Liu GF, Wang CJ, Liu LP, Yang XM, Jiao Y, Jiao Y, Wang LS, Wang YJ and Gu WK. High-sensitivity C-reactive protein is a strong risk factor for death after acute ischemic stroke among Chinese. CNS Neurosci Ther 2012; 18: 261-266.
39. Hudson RS, Yi M, Esposito D, Watkins SK, Hurwitz AA, Yfantis HG, Lee DH, Borin JF, Naslund MJ, Alexander RB, Dorsey TH, Stephens RM, Croce CM and Ambs S. MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res 2012; 40: 3689-3703.